Search

中文 / English

Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
 Copyright: Beijing Minhai Biological Technology Co., Ltd.   
Beijing ICP 10007676    Powered by  www.300.cn Beijing    Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173

Contact

Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Recruitment: 010-59613633
Marketing: 010-59613639
Medical support: 010-59613669

Links:

>
>
Entreprise's news
R & D and innovation have achieved great results, making vaccines beneficial to the people
$info.title
ShenzhenKangtaiBiologicalProductsCo.,Ltd.,theparentcompanyofBeijingminhaiBiotechnologyCo.,Ltd.(hereinafterreferredtoasKangtaibiologicalproducts),isalistedenterprisemainlyengagedintheresearchanddevelop
Daxing District is the first municipal project approved to start construction preparation letter, which is the international industrial base of new type vaccine for human sea organisms
$info.title
OnJune11,2020,DaxingDistrict,Beijing,thefirstmunicipalprojecttoobtainthe"constructionpreparationletter"wasapprovedtostartconstruction.EcompanyreporterlearnedthattheprojectislocatedinDaxingDistrictbiom
Disseminate vaccine knowledge to thousands of households,Kangtai Biology, the parent company of Minhai Biology, became China's first vaccine science base
$info.title
On December 10, 2019, the awarding ceremony of the first vaccine science base of the Chinese Preventive Medicine Association was held in Shenzhen. The base was settled in the production base of Kangtai Biological Bright Area, the parent company of Minhai Biological.
Minhai Biology was included in the 2019 Beijing Private Enterprises Top 100 Technology Innovation List
$info.title
Following the first release last year, this morning (November 15), the Beijing Federation of Industry and Commerce once again released the 2019 "Top 100 Private Enterprises in Beijing", "Top 100 Private Enterprises in Science and Technology Innovation", "Top 100 Cultural Enterprises in Beijing Private Enterprises"
Pneumonia "nemesis": Minhai Biological 23-valent pneumococcal vaccine successfully launched
$info.title
On August 13, 2019, the 23-valent pneumococcal polysaccharide vaccine produced by Beijing Minhai Biological Technology Co., Ltd. (hereinafter referred to as Minhai Biological) successfully passed the review of the State Drug Administration
Page up
1
2
...
11